Company intelligence / Profile preview
Ethicann Pharmaceuticals
Calgary, Alberta, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Ethicann is reformulating approved cannabinoid drugs (THC/CBD ethanol spray) into Zydis ODT sublingual tablets (e.g., EPI-002) and related formulations, pursuing abbreviated approval pathways (e.g., 505(b)(2), Canadian BE-based route) for indications such as MS spasticity, CINV, chronic pain, epilepsy, and opioid dependence. Its lead program, a cannabidiol/tetrahydrocannabinol formulation (EPI-002) for MS spasticity, has completed positive animal PK/feasibility work and is moving into human bioequivalence studies required for marketing approval in Canada and subsequently other regions.
- Therapeutic areas
- OncologyNeurologyPsychiatry
- Modalities
- Small moleculeCannabinoidSynthetic oligonucleotide
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Catalent – development and license agreement to use **Zydis ODT** technology for Ethicann’s cannabinoid drug pipeline, including MS spasticity, CINV, chronic pain in cancer, and epilepsyIlera Therapeutics – partnership to develop and manufacture highly purified botanical THC-based product for CINV clinical study
Beyond the preview
Go deeper on Ethicann Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ethicann Pharmaceuticals.